Lung cancer is the leading cause of cancer deaths worldwide, and early detection is key: there is a 12-fold increase in five-year survivorship between those detected at stage one versus stage four.

NeXT Personal identifies circulating tumor DNA in 81% of early-stage lung adenocarcinoma cases, offering potential for better disease stratification and outcome prediction. Study: Ultrasensitive ctDNA ...